ARNA had to be one of the worst short attacks I've seen in a while. Once the Rat data became public, it has been relentless. Biotech is definitely not for the weak at heart.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.